FDA OKs use of bivalent vaccines

  • This August photo provided by Pfizer shows packaging for the company's updated COVID-19 vaccine during production in Kalamazoo, Mich. (Pfizer via AP)

The U.S. Food and Drug Administration on Wednesday granted emergency use authorization for the first bivalent vaccines to protect against the original strain of COVID-19 and the omicron subvariants.